Patents by Inventor Hans-Jürgen Mägert

Hans-Jürgen Mägert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149522
    Abstract: Polypeptide having an amino acid sequence selected from at least 70% sequence identity to any one of domains 1 to 14 of LEKTI, SPINK6 or SPINK9-polypeptide for use in the treatment of a viral infection with a virus, in the infection of which serine proteinases are involved, and slowing down the spread of infection of said virus.
    Type: Application
    Filed: March 29, 2021
    Publication date: May 18, 2023
    Inventors: Wolf-Georg Forssmann, Hans-Jürgen Mägert
  • Patent number: 6939851
    Abstract: The invention relates to serine protease inhibitors having the amino acid sequence in accordance with Seq. ID No. 1.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: September 6, 2005
    Assignee: Pharis Biotec GmbH
    Inventors: Wolf-Georg Forssmann, Hans-Jürgen Mägert, Ludger Ständker, Peter Kreutzmann
  • Patent number: 6579849
    Abstract: A peptide having the amino acid sequence H2N—X1—R—X3—X2—COOH  (formula I) wherein X1 is either zero or X1 and/or X2 are a residue representing at least five amino acid residues (symbolized in the one letter amino acid code), preferably naturally occurring amino acids, with the proviso that X1 and/or X2 contain at least one basic amino acid residue immediately followed by a hydrophobic amino acid residue and X1 and/or X2 contain at least one glutamine residue.
    Type: Grant
    Filed: September 24, 1998
    Date of Patent: June 17, 2003
    Assignee: HaemoPep Pharma GmbH
    Inventors: Wolf-Georg Forssmann, Hans-Dieter Zucht, Manfred Raida, Knut Adermann, Hans-Jürgen Mägert